Management of Hypersensitivity Reactions to Carboplatin and Paclitaxel in an Outpatient Oncology Infusion Center: A 5-Year Review
- 1 July 2014
- journal article
- review article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 2 (4) , 428-433
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Ovarian CancerClinical Obstetrics and Gynecology, 2012
- A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactionsJournal of Allergy and Clinical Immunology, 2012
- Rapid Desensitization for Hypersensitivity Reactions to MedicationsImmunology and Allergy Clinics of North America, 2009
- Risk stratification for desensitization of patients with carboplatin hypersensitivity: Clinical presentation and managementJournal of Allergy and Clinical Immunology, 2009
- Management and Preparedness for Infusion and Hypersensitivity ReactionsThe Oncologist, 2007
- Clinical features and severity grading of anaphylaxisJournal of Allergy and Clinical Immunology, 2004
- Hypersensitivity Reactions to Carboplatin Administration Are Common but Not Always Severe: A 10-Year ExperienceOncology, 2001
- Carboplatin Skin Testing: A Skin-Testing Protocol for Predicting Hypersensitivity to Carboplatin ChemotherapyJournal of Clinical Oncology, 2001
- Prevention and Management of Antineoplastic-Induced Hypersensitivity ReactionsDrug Safety, 2001
- Paclitaxel-Associated Hypersensitivity Reactions: Experience of the Gynecologic Oncology Program of the Cleveland Clinic Cancer CenterJournal of Clinical Oncology, 2000